LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.94 | 770.25 | 3387 | 8444 | 0.4011 | 0.5353 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 58.94 | 770.25 | 4717 | 8444 | 0.5586 | 0.6898 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 61.16 | 770.25 | 3554 | 8892 | 0.3997 | 0.5423 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 61.16 | 770.25 | 5004 | 8892 | 0.5628 | 0.6993 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 63.39 | 770.25 | 3737 | 9326 | 0.4007 | 0.5511 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 63.39 | 770.25 | 5233 | 9326 | 0.5611 | 0.7033 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 65.61 | 770.25 | 3929 | 9736 | 0.4036 | 0.5608 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 65.61 | 770.25 | 5537 | 9736 | 0.5687 | 0.7142 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.83 | 770.25 | 4161 | 10078 | 0.4129 | 0.5757 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 67.83 | 770.25 | 5752 | 10078 | 0.5707 | 0.7194 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 70.05 | 770.25 | 4326 | 10413 | 0.4154 | 0.5830 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 70.05 | 770.25 | 5961 | 10413 | 0.5724 | 0.7240 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 72.27 | 770.25 | 4514 | 10730 | 0.4207 | 0.5925 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 72.27 | 770.25 | 6210 | 10730 | 0.5787 | 0.7319 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 74.50 | 770.25 | 4698 | 10991 | 0.4274 | 0.6024 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 74.50 | 770.25 | 6478 | 10991 | 0.5894 | 0.7424 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.75 | 770.25 | 4947 | 11262 | 0.4392 | 0.6170 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.75 | 770.25 | 6755 | 11262 | 0.5998 | 0.7525 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.98 | 770.25 | 5124 | 11518 | 0.4449 | 0.6251 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.98 | 770.25 | 6958 | 11518 | 0.6041 | 0.7577 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 81.20 | 770.25 | 5292 | 11766 | 0.4498 | 0.6323 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 81.20 | 770.25 | 7190 | 11766 | 0.6111 | 0.7646 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 83.42 | 770.25 | 5470 | 12031 | 0.4546 | 0.6394 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 83.42 | 770.25 | 7408 | 12031 | 0.6157 | 0.7698 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 85.64 | 770.25 | 5626 | 12287 | 0.4579 | 0.6448 | MN20160304_L02 | D16 |